Back to top
more

Biotechnology Ultra Sector Pro Fund, Service: (MF: BIPSX)

(NASDAQ Mutual Funds) As of Jan 20, 2018 10:58 PM ET

 Add to portfolio

$54.67 USD

+0.43 (0.79%)

Zacks MF Rank 3-Hold     3    

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Dec 31, 2017

Total Return %* Percentile Rank Objective
YTD 33.36 6
3 months -7.71 99
6 months 8.92 8
1 Year 33.37 6
3 Year 0.90 92
5 Year 25.87 1
10 Year 19.35 1

* Annual for three years and beyond.

Zacks Premium Research for BIPSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Hold 3
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 34.56
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 12/31/2017 12.72
%Turnover 12/31/2017 14.00

Risk

3 Year 5 Year 10 Year
Beta 1.94 2.04 1.09
Alpha -14.73 -2.71 12.72
R Squared 0.40 0.40 0.31
Std. Dev. 30.63 30.52 29.56
Sharpe 0.18 1.03 3.00

Sector / Country Weightings

As of 12/31/2017 % of Portfolio
Other 39.11
Health 36.24
Services 15.78
Industrial Cyclical 6.10
Technology 2.77

Portfolio Holdings

Top Equity Holdings
(As of 10/31/2017)
% of Portfolio Value (Mil$)
ABBVIE INC 13.32 44.93
AMGEN INC 11.84 39.93
GILEAD SCIENCES INC 9.06 30.57
CELGENE CORP 7.31 24.67
BIOGEN IDEC INC 6.10 20.58
VERTEX PHARMACEUTICALS IN 3.41 11.51
REGENERON PHARMACEUTICALS 2.86 9.66
ILLUMINA INC 2.77 9.36
ALEXION PHARMACEUTICALS I 2.47 8.34

Stock Holding % of Net Assets

As Of 10/31/2017
Total Issues 39
Avg. P/E 40.79
Avg. P/Book 5.95
Avg. EPS Growth 15.87
Avg. Market Value (Mil $) 78,504

Allocation

% of Portfolio
Large Growth 10.70
Large Value 8.86
Small Growth 0.00
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 4.23
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 16.88